US 10047147
Neutralizing GP41 antibodies and their use
granted A61KA61K2039/505A61K39/42
Quick answer
US patent 10047147 (Neutralizing GP41 antibodies and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K39/42, A61K45/06, A61K49/0004